ARTIFICIAL BLOOD
July 1st, 2005
BY KEITH NUTHALL and MONICA DOBIEA EUROPEAN Union (EU)-sponsored research project has been launched to create practical cell-factories producing a genetically-modified haemogoblin, the key element of blood that carries oxygen around the body. The Euro Blood Substitutes initiative wants to use 'Aspergillus niger' fungus and 'Escherichia coli' bacteria to create super-charged haem proteins, helping create reliable supplies of alternative blood products. The bacteria and the fungus are already widely used as pharmaceutical cell factories. The goal said a European ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.